spacer

International Clinical Trials
International Clinical Trials
ICT is a specialist journal designed to provide global coverage of key topics pertinent to the clinical trials sector.
 
European Pharmaceutical Contractor
European Pharmaceutical Contractor
The EPC edition is designed to fill a unique position in pharmaceutical contractor publishing.
 
European Biopharmaceutical Review
European Biopharmaceutical Review
EBR is well-recognised for providing beneficial information to players in the bio-industry including entrepreneurial biopharmaceutical and life science companies
 
Pharmaceutical Manufacturing and Packing Sourcer
Pharmaceutical Manufacturing and Packing Sourcer
PMPS is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.
 
Innovations in Pharmaceutical Technology
Innovations in Pharmaceutical Technology
IPT was launched in 1997 to provide the pharmaceutical industry with quality information on the latest cutting-edge technologies.
 
Therapeutic Focus: Dementia
New Frontiers in Alzheimer’s Disease Research

The Practical Alternative

The failures of Alzheimer’s disease research have opened up new approaches to achieve an earlier diagnosis and a more effective treatment approach, argues Timothy Earle at TauRx Theraputics.
 
Good Clinical Practice
GCP Audit Preparation

Unfamiliar Grounds

Closed Loop Quality’s Iain Pulley imparts his knowledge on GCP audit processes and how to ensure the audit team is suitably prepared for effective review.
 
Features
Medicinal Cannabis

Why the Regulation of CBD Isn’t ABC

Greer Deal at Global Regulatory Services maps the controversial history of cannabis, the fast-changing regulations for cannabisderived products, and the effect all the aforementioned may have on the market for cannabis-based drugs.
 
Feature topics
Adapting to EU Regulations

Regulation, Regulation, Regulation

Elizma Parry at Maetrics examines legislation surrounding medical device regulations adopted in 2017 and the upheaval this may cause for those in the industry developing companion diagnostics or combination products.

 

 

Website design and development by Rubler Studio
spacer

Member login

E-mail address:

Password:
Remember me

.
News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

.
White Papers

Wrap Around Label - A Lot of Content in a Small Space

Faubel & Co. Nachfolger GmbH

One of the world’s largest contract research organizations for the planning and conducting of clinical trials was faced with the challenge of accommodating many different national languages on an inhaler. The inhaler was then to be distributed in 47 countries. Due to the impressive quality and reliable collaboration, the organization commissioned Faubel with finding the optimal labeling solution for the inhaler.
More info >>



Industry Events

ESMO Targeted Anticancer Therapies Congress 2020

2-4 March 2020, Paris, France

A unique and international mix of experts, researchers and decision makers both from academia and industry across the globe, will convene in Paris for a three-day Congress aiming at exchanging knowledge, experience and research innovations in cancer. TAT 2020 will focus, among others, on novel strategies in immuno-oncology, personalised medicine and molecular tumour boards, preclinical studies to identify effective combination therapies, use of microbiome, tumour agnostic trials, ADC technology, oncolytics, multispecific biological constructs and targeting cytokines. Participating in TAT 2020 will offer you the possibility to take part in interdisciplinary discussions inspiring new ideas and new collaborations.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement